Cargando…

Chitosan-based nanoparticles in Alzheimer’s disease: messenger or message?

Detalles Bibliográficos
Autores principales:	Manek, Eniko, Petroianu, Georg A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354127/ https://www.ncbi.nlm.nih.gov/pubmed/33818494 http://dx.doi.org/10.4103/1673-5374.310685

Ejemplares similares

Use of Biodegradable, Chitosan-Based Nanoparticles in the Treatment of Alzheimer’s Disease
por: Manek, Eniko, et al.
Publicado: (2020)

Nanoparticle-Mediated Cytoplasmic Delivery of Messenger RNA Vaccines: Challenges and Future Perspectives
por: Wu, Zimei, et al.
Publicado: (2021)

A Mitochondrial Encoded Messenger at the Nucleus
por: Yong, Cheryl Qian Ying, et al.
Publicado: (2018)

Framing vaccine mandates: messenger and message effects
por: Buccafusco, Christopher, et al.
Publicado: (2022)

COVID-19: the medium is the message
por: Garrett, Laurie
Publicado: (2020)

Messengers and Messages for Tweets That Used #thinspo and #fitspo Hashtags in 2016
por: Harris, Jenine K., et al.
Publicado: (2018)

Topicality and Impact in Social Media: Diverse Messages, Focused Messengers
por: Weng, Lilian, et al.
Publicado: (2015)

Nitric Oxide: The Coming of the Second Messenger*
por: Murad, Ferid
Publicado: (2011)

Delivering emoji/icon-based universal health education messages through smartphones
por: Bhattacharya, Sudip, et al.
Publicado: (2019)

Chitosan Schiff-Base Hydrogels—A Critical Perspective Review
por: Duceac, Ioana A., et al.
Publicado: (2022)

Allergy evaluation of messenger RNA vaccine reactions is crucial, with a specific role for polyethylene glycol testing
por: Shrestha, Pragya, et al.
Publicado: (2022)

The shot, the message, and the messenger: COVID-19 vaccine acceptance in Latin America
por: Argote, Pablo, et al.
Publicado: (2021)

The semiotics of the message and the messenger: How nonverbal communication affects fairness perception
por: Spapé, Michiel, et al.
Publicado: (2019)

Targeting the guanine-based purinergic system in Alzheimer's disease
por: Lanznaster, Débora, et al.
Publicado: (2017)

Messaging in Biological Psychiatry: Misrepresentations, Their Causes, and Potential Consequences
por: Dumas-Mallet, Estelle, et al.
Publicado: (2020)

Preventative medicine and Alzheimer’s disease: is Alzheimer’s disease risk reduction achievable?
por: Sinyor, Benjamin, et al.
Publicado: (2021)

Alzheimer's disease in Down syndrome: An overlooked population for prevention trials
por: Strydom, André, et al.
Publicado: (2018)

Recognizing the message and the messenger: biomimetic spectral analysis for robust speech and speaker recognition
por: Nemala, Sridhar Krishna, et al.
Publicado: (2012)

The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
por: Walgrave, Hannah, et al.
Publicado: (2021)

Endocannabinoid metabolism and Alzheimer's disease
por: Chen, Chu
Publicado: (2022)

OxInflammation in Alzheimer’s disease
por: Cervellati, Carlo, et al.
Publicado: (2023)

Emerging small-molecule therapeutic approaches for Alzheimer's disease and Parkinson's disease based on targeting microRNAs
por: Abdelrahman, Somaya A., et al.
Publicado: (2021)

Pregnancy should be a condition eligible for additional doses of COVID-19 messenger RNA vaccines
por: Faust, Jeremy Samuel, et al.
Publicado: (2023)

Advancing combination therapy for Alzheimer's disease
por: Salloway, Stephen P., et al.
Publicado: (2020)

Translational animal models for Alzheimer's disease: An Alzheimer's Association Business Consortium Think Tank
por: Vitek, Michael P., et al.
Publicado: (2021)

Nilotinib: from animal-based studies to clinical investigation in Alzheimer’s disease patients
por: Nobili, Annalisa, et al.
Publicado: (2022)

How can we better frame COVID-19 public health messages?
por: Teye-Kwadjo, Enoch
Publicado: (2022)

Trusted messengers and trusted messages: The role for community-based organizations in promoting COVID-19 and routine immunizations
por: Shen, Angela K., et al.
Publicado: (2023)

Probiotics, prebiotics and their role in Alzheimer’s disease
por: D'Argenio, Valeria, et al.
Publicado: (2021)

Next generation therapeutics for Alzheimer's disease
por: Bredesen, Dale E, et al.
Publicado: (2013)

New Approaches to Treating Alzheimer’s Disease
por: Zheng, Hailin, et al.
Publicado: (2015)

The pathway to secondary prevention of Alzheimer's disease
por: McDade, Eric, et al.
Publicado: (2020)

Alzheimer’s Disease is a Disorder of Consciousness
por: Yokoi, Teruo
Publicado: (2023)

Open drug discovery in Alzheimer's disease
por: Axtman, Alison D., et al.
Publicado: (2023)

Reevaluating the cause of laminopathy in Alzheimer’s disease
por: Islam, Md Imamul, et al.
Publicado: (2023)

The Text4HealthyAging Program: An Evidence-Based Text Messaging Innovation to Support Healthy Urban Aging in Canada and Australia
por: Eboreime, Ejemai, et al.
Publicado: (2022)

Leading the World’s Premier Environmental Health Organization: A Message from Linda Birnbaum
por: Birnbaum, Linda S.
Publicado: (2009)

Designing text-messaging (SMS) in HIV programs: ethics-framed recommendations from the field
por: Pérez, Guillermo Martínez, et al.
Publicado: (2015)

Intercellular Signaling in Cancer—the SMT and TOFT Hypotheses, Exosomes, Telocytes and Metastases: Is the Messenger in the Message?
por: Smythies, John
Publicado: (2015)

Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study
por: Desai, Rishi J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vsjt5lt3k15abi56urd3qpeqqp